~~<i id='E10DEF04A4'><strike id='E10DEF04A4'><tt id='E10DEF04A4'><pre id='E10DEF04A4'></pre></tt></strike></i>~~

Home» explore» comprehensive

comprehensive

author：explore 2025-10-04 08:51:51 Page View：72

Senate health committee Chair Bernie Sanders — Sen. Berne Sanders (I-Vt.) Kevin Dietsch/Getty Images

WASHINGTON — Sen. Bernie Sanders (I-Vt.) has a new corporate target: the food industry.

Sanders held a hearing today on diabetes that implicated both the food and drug industries in what the American Diabetes Association estimates is a $413 billion annual cost to the health care system. That’s up 27% over the past six years, he said, and he warned that new weight loss drugs could send health care spending to the stratosphere.

But the food industry received more attention, especially from Sanders, than the drugmakers and drug middlemen.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Fetal surgery at risk from Dobbs and new abortion restrictions
Next article： After affirmative action ruling, medical educators look to 'holistic review'

explore

Jerome Adams on the need for new antivirals for Covid

PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

Readout LOUD podcast: possible new ALS drug, artificial wombs

CantheFDAbetooflexible?Howdoyoutestamechanicalwomb?Andwhodecideswhat’sgoodenoughforpatientsinneed?We

The cancer drug shortage isn’t new — and neither are the solutions

PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

J&J to emphasize cancer drugs, stop much of its vaccine research

DanielHulshizer/APEightmonthsintohistenure,Johnson&Johnson’sR&Dchiefisputtingabigemphasisonm